Abstract: A method configured to implemented on at least one image processing device for detecting objects in images includes obtaining an image including an object. The method also includes generating one or more feature vectors related to the image based on a first convolutional neural network, wherein the one or more feature vectors includes a plurality of parameters. The method further includes determining the position of the object based on at least one of the plurality of parameters. The method still further includes determining a category associated with the object based on at least one the plurality of parameters.

Abstract: A vehicle system comprises a processor programmed to responsive to a successful authentication of a user, launch a payment application and establish a wireless communication with a payment terminal; exchange a security certificate with the payment terminal; and authorize a transaction by transmitting transaction information including ECU information to the payment terminal.

Abstract: Systems and methods for utilizing laboratory equipment in a hybrid reality environment or augmented virtual reality environment, are contemplated herein and include: at least one piece of laboratory equipment having at least one feature, wherein the at least one piece of laboratory equipment is tracked; a tracking module for tracking a position and an orientation of the at least one piece of tracked laboratory equipment; a virtual model, stored in a memory, comprising at least one 3-D virtual representation of the at least one feature of the at least one piece of laboratory equipment; and an experimentation module.

Abstract: The present invention provides a human PD-1 antibody, an antigen-binding fragment thereof, and medical use thereof, and further provides a chimeric antibody and humanized antibodies comprising a complementarity-determining region (CDR) of the antibody, a pharmaceutical composition comprising the human PD-1 antibody and the antigen-binding fragment thereof, and use of the antibody in preparing medicines for treating diseases or disorders.

Abstract: An electronic device includes a first body, a second body, and a palm component. One end of the first body comprises a supporting portion. The second body is pivotally connected to a first side of the supporting portion and comprises a sliding portion. The palm component is pivotally connected to a second side of the supporting portion and comprises a guiding portion. The sliding portion is movably connected to the guiding portion. When the first body is pivotally rotated and expended relative to the second body, the second body is driven to make the sliding portion move along the guiding portion, and the second side of the supporting portion rotates relative to the first end of the supporting portion to make the palm component protrude from the second body. A tilt angle is formed between the second body and the protruding palm component.

Abstract: A highly parallel microfluidic blood separation device for isolation of variety of analytes for large-scale clinical trials. The device can be utilized for isolation of number of different target analytes, which may be the starting materials for variety of diagnostic methods including NGS, PCR, FISH, IHC, and others. Separation is achieved via magnetic sheath flow principals and is highly parallel. The separation device achieves effective magnetic separation, functions during sample flow in a vertical geometry and may fasten to standard multi-well plates for highly multiplexed sample recovery. Operating in vertical orientation allows multiplexing, more cards/slot/bay on instrument, allows effective use of real estate on instruments and bench tops.

Abstract: A mask includes a mask body and at least one sub-mask provided on the mask body. The sub-mask includes an evaporation zone and a shield portion. The shield portion is provided with at least one groove in a thickness direction of the sub-mask. The groove has a depth smaller than a thickness of the mask body. Since the shield portion is provided with the groove, and a single groove has a depth smaller than the thickness of the mask body, it not only ensures that there is no pixel evaporated onto a substrate at the shield portion, but also reduces the thickness of the shield portion, thereby reduces weight thereof, lowers the weight difference between the shield portion and the evaporation zone and reduces the stress concentration on the shield portion, resulting in that the mask body is evenly stressed during tensioning.

Abstract: The present disclosure relates to a heat dissipation hole structure of a flip-type electronic device. The heat dissipation hole structure includes a first connecting rod, a second connecting rod, and a blade group. The flip-type electronic device includes a base, an upper cover, and a pivot. Two ends of the first connecting rod are respectively pivoted to the pivot and the second connecting rod. The second connecting rod is further pivoted to the blade group. The blade group is disposed in an opening of the base and includes two blades. The two blades are both pivoted to an inner surface of the opening, and one end of each of the two blades is slidably connected to each other. In this way, when the upper cover is opened, the pivot drives the blade group through the first connecting rod and the second connecting rod, so that the two blades rotate.

Abstract: An electronic device includes a first body, a second body, and a palm component. One end of the first body comprises a supporting portion. The second body is pivotally connected to a first side of the supporting portion and comprises a sliding portion. The palm component is pivotally connected to a second side of the supporting portion and comprises a guiding portion. The sliding portion is movably connected to the guiding portion. When the first body is pivotally rotated and expended relative to the second body, the second body is driven to make the sliding portion move along the guiding portion, and the second side of the supporting portion rotates relative to the first end of the supporting portion to make the palm component protrude from the second body. A tilt angle is formed between the second body and the protruding palm component.

Abstract: Embodiments of the present disclosure provide a method for monitoring a circuit breaker, comprising the following steps: obtaining a characteristic force associated with an actuating mechanism of the circuit breaker over the time; and determining the time point when the closing and/or opening of the circuit breaker occurs by identifying a variation of the force. The step of determining further comprises determining the moment when a variation increase of the characteristic force occurs as the time point of the closing of the circuit breaker; and determining the moment when a variation decrease of the characteristic force occurs as the time point of the opening of the circuit breaker. The method can be used to accurately on-line monitor the closing and opening time point of the circuit breaker.

Abstract: The present invention provides a human PD-1 antibody, an antigen-binding fragment thereof, and medical use thereof, and further provides a chimeric antibody and humanized antibodies comprising a complementarity-determining region (CDR) of the antibody, a pharmaceutical composition comprising the human PD-1 antibody and the antigen-binding fragment thereof, and use of the antibody in preparing medicines for treating diseases or disorders.

Abstract: A first electronic control unit (ECU) is in communication with a second ECU over a vehicle bus. The first ECU is configured to generate functional safety values and security protection values for a message, validate the security protection values for the message, and send the message to the second ECU including the security protection values but not the functional safety values.

Abstract: Various embodiments of systems and methods for collision-free trajectory planning in human-robot interaction through hand movement prediction from vision are disclosed.

Abstract: An interleukin 15 (IL-15) protein complex is provided. The IL-15 protein complex includes soluble fusion proteins (I) and (II), wherein the fusion protein (I) is an IL-15 polypeptide or a functional fragment thereof, and the soluble fusion protein (II) is an IL-15R? polypeptide or a functional fragment thereof. The soluble fusion protein (I) has at least one amino acid residue mutated to a cysteine (Cys) residue, which pairs with a corresponding mutated Cys residue on the soluble fusion protein (II), or vice versa, to form one or more disulfide bonds. The IL-15 protein complex can be used for tumor therapy.

Abstract: A gateway including a hardware security module (HSM) implementing a hardware random number generator and a non-transitory memory maintaining a key injection status table (KIST). The gateway is programmed to distribute keys generated using the random number generator to a plurality of electronic control units (ECUs) responsive to a trigger to begin key distribution received from an end-of-line (EOL) tool, and send the KIST to the EOL tool responsive to completion of the key distribution. A key generated using a hardware random number generator is sent in an encrypted message to a vehicle electronic control unit (ECU), responsive to receiving a unique identifier (UID) of the ECU over a vehicle bus. Responsive to an indication of success from the ECU in a second encrypted message, a key injection status table (KIST) is updated to indicate that the key was applied to the ECU.

Abstract: Provided is an IL-15 heterodimeric protein, such as an IL-15/IL-15R? heterodimeric protein. The IL-15 heterodimeric protein contains protein (I) and protein (II). Protein (I) is recombinantly produced by combining IL-15 or a variant thereof with a first Fc variant, and protein (II) is a second Fc variant, or recombinantly produced by combining IL-15R? or a variant thereof with a second Fc variant. The first Fc variant and the second Fc variant are preferably linked via a “Knob-into-Hole” mode. Also provided are methods of using the IL-15 heterodimeric proteins to modulate an immune response. The provided IL-15 heterodimeric proteins have significant anti-tumor activity, better biological activity and prolonged in vivo half-life compared to the IL-15 molecule alone.

Abstract: A pivot supporting structure for a circuit breaker and a circuit breaker. The pivot supporting structure includes: a supporting body having a supporting hole for receiving and pivotally supporting a pivot pin connected to an actuating mechanism of the circuit breaker, wherein at least one strain gauge are mounted to the supporting body for sensing the force acting on the pivot supporting structure by the actuating mechanism. This pivot supporting structure can accurately sense the characteristic force applied, such that the contact force and mechanical characteristics of the circuit breaker can be on-line monitored.

Abstract: The present invention provides a PCSK9 antibody, an antigen-binding fragment thereof, and a medicinal application thereof. Provided in the invention is a chimeric antibody and a humanized antibody, both comprising a CDR of the PCSK9 antibody, and a pharmaceutical composition comprising the PCSK9 antibody and an antigen-binding fragment thereof, and an application of the PCSK9 antibody as a lipid-lowering agent. The invention specifically relates to an application of a humanized PCSK9 antibody for preparing a pharmaceutical drug to treat a PCSK9-induced disease or symptom.

Abstract: Method and apparatus are disclosed for remote keyless entry authentication. An example remote keyless entry system includes a key fob and a vehicle. The key fob generates a secured message with a plaintext space and a ciphertext space. The vehicle (i) determines whether the key fob may be authorized based on first information in the plaintext space, (ii) decrypts an encrypted value in the ciphertext space based on a predicted full counter value, and (iii) determines whether the key fob is authorized based on second information in the encrypted value.

Abstract: Method and apparatus are disclosed for end-to-end vehicle secure ECU unlock in a semi-offline environment. An example vehicle electronic control unit includes a first processor and a second processor. The first processor, when unlocked, provides diagnostic information. The second processor sends a seed value to a diagnostic tool. Additionally, the second processor, in response to receiving a second key, unlocks the first processor. The second processor, after receiving a first verifier, decrypts the first verifier to generate a new key, replaces a current key with the new key, and sends a second verifier to the diagnostic tool.